Reducing biopharmaceutical manufacturing costs through continuous processing in a flexible J.POD® facility

Drug Discov Today. 2023 Jul;28(7):103619. doi: 10.1016/j.drudis.2023.103619. Epub 2023 May 16.

Abstract

In this work, process models were developed to capture the impact of biomanufacturing costs on a commercial scale and emphasize the way in which facility design and operation must balance meeting product demand while minimizing production costs. Using a scenario-based modeling approach, several facility design strategies were evaluated, including a traditional large stainless-steel facility and a small footprint, portable-on-demand (POD)-based facility. Bioprocessing platforms were compared by estimating their total production costs across different facility types and specifically illustrating how continuous bioprocessing has gained in popularity as a novel and cost-effective approach to manufacture high-quality biopharmaceuticals. The analysis showed how fluctuations in market demand have a dramatic effect on manufacturing costs and plant utilization, with far-reaching implications on the total cost to patients.

Keywords: continuous bioprocessing; economic modeling; facility design; flexible manufacturing.

MeSH terms

  • Biological Products* / economics
  • Drug Industry* / economics

Substances

  • Biological Products